|
|
Volumn 28, Issue 3, 2010, Pages 185-186
|
|
GSK/Sirtris compounds dogged by assay artifacts
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
RESVERATROL;
SIRTUIN 1;
SRT 501;
UNCLASSIFIED DRUG;
AGING;
ARTIFACT;
BIOTECHNOLOGY;
CALORIC RESTRICTION;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG DETERMINATION;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
DRUG TARGETING;
ENZYME ACTIVATION;
HUMAN;
LONGEVITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PUBLICATION;
ANIMALS;
DRUG INDUSTRY;
HUMANS;
LONGEVITY;
MICE;
SIRTUIN 1;
STILBENES;
|
|
EID: 77749317552
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0310-185 Document Type: Note |
|
Times cited : (30)
|
|
References (0)
|
